Michael Doherty
Impact in
- Rheumatology top 0.01%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Nephrology top 0.02%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Rheumatology 237
- Osteoarthritis Treatment and Mechanisms 153
- Rheumatoid Arthritis Research and Therapies 48
- Musculoskeletal synovial abnormalities and treatments 18
- Systemic Lupus Erythematosus Research 15
- Nephrology 97
- Gout, Hyperuricemia, Uric Acid 95
- Co-authors
- Weiya Zhang (208 shared papers)Matthew J. Grainge (30 shared papers)Edward Roddy (22 shared papers)Kenneth Muir (43 shared papers)Paul Dieppe (27 shared papers)Abhishek Abhishek (59 shared papers)Sally Doherty (42 shared papers)Marc C. Hochberg (11 shared papers)
- Journals
- Annals of the Rheumatic Diseases (126 papers)Lara D. Veeken (73 papers)Osteoarthritis and Cartilage (54 papers)Arthritis Care & Research (17 papers)Arthritis Research & Therapy (12 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Michael Doherty
568 papers receiving 32.4k citations
Michael Doherty's Hit Papers
Peers
Comparison fields: 5 of 205
- Rheumatology 13.4k
- Nephrology 6.1k
- Pharmacology 4.0k
- Orthopedics and Sports Medicine 1.9k
- Surgery 6.4k
Countries citing papers authored by Michael Doherty
This map shows the geographic impact of Michael Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doherty more than expected).
Fields of papers citing papers by Michael Doherty
This network shows the impact of papers produced by Michael Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doherty. The network helps show where Michael Doherty may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Doherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 588 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines Hit paper breakdown → | 2008 | 2148 |
| 2 | OARSI recommendations for the management of hip and knee osteoarthritis Hit paper breakdown → | 2010 | 1257 |
| 3 | Global epidemiology of gout: prevalence, incidence and risk factors Hit paper breakdown → | 2015 | 844 |
| 4 | Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Hit paper breakdown → | 1998 | 768 |
| 5 | OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence Hit paper breakdown → | 2007 | 591 |
| 6 | EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis Hit paper breakdown → | 2009 | 512 |
| 7 | The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies Hit paper breakdown → | 2017 | 501 |
| 8 | Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial Hit paper breakdown → | 2004 | 496 |
| 9 | 2008 | 478 | |
| 10 | Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study Hit paper breakdown → | 2014 | 460 |
| 11 | 1998 | 433 | |
| 12 | 2007 | 409 | |
| 13 | 2004 | 364 | |
| 14 | 1999 | 354 | |
| 15 | 1999 | 339 | |
| 16 | 2011 | 338 | |
| 17 | 2002 | 319 | |
| 18 | 2018 update of the EULAR recommendations for the management of hand osteoarthritis Hit paper breakdown → | 2018 | 318 |
| 19 | Paracetamol: not as safe as we thought? A systematic literature review of observational studies Hit paper breakdown → | 2015 | 289 |
| 20 | 1992 | 287 |
About Michael Doherty
Michael Doherty is a scholar working on Rheumatology, Nephrology, Surgery, Pharmacology and Physiology, having authored 588 papers that have together received 33.9k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (153 papers), Gout, Hyperuricemia, Uric Acid (95 papers), Rheumatoid Arthritis Research and Therapies (48 papers), Inflammatory mediators and NSAID effects (34 papers), Musculoskeletal pain and rehabilitation (18 papers), Musculoskeletal synovial abnormalities and treatments (18 papers), Case Reports on Hematomas (16 papers) and Systemic Lupus Erythematosus Research (15 papers). The work is most often cited by research in Rheumatology (13.4k citations), Nephrology (6.1k citations), Pharmacology (4.0k citations), Orthopedics and Sports Medicine (1.9k citations) and Surgery (6.4k citations). Michael Doherty has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Weiya Zhang, Matthew J. Grainge, Edward Roddy, Kenneth Muir, Paul Dieppe, Abhishek Abhishek, Sally Doherty, Marc C. Hochberg, Chang‐Fu Kuo and Frances Rees. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Osteoarthritis and Cartilage, Arthritis Care & Research and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.